Kimberly-Clark will buy Kenvue for $48.7 billion. Kenvue is the maker of Tylenol. Kenvue just beat earnings in its Q3 2025 report. The good news for Kenvue is that the bad press didn't prevent the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback